IOVANCE BIOTHERAPEUTICS INC's ticker is and the CUSIP is 462260900. A total of 4 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,463,280 | +211.6% | 321,600 | +382.2% | 0.00% | – |
| Q2 2023 | $469,568 | +91.7% | 66,700 | +66.3% | 0.00% | – |
| Q1 2023 | $245,011 | -79.1% | 40,100 | -78.2% | 0.00% | -100.0% |
| Q4 2022 | $1,173,204 | -3.9% | 183,600 | +44.0% | 0.00% | 0.0% |
| Q3 2022 | $1,221,000 | -54.9% | 127,500 | -48.1% | 0.00% | 0.0% |
| Q2 2022 | $2,710,000 | – | 245,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 324,500 | $8,908,000 | 0.04% |
| JPMORGAN CHASE & CO | 710,100 | $19,492,000 | 0.00% |
| SIMPLEX TRADING, LLC | 607 | $1,666,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |